Suppr超能文献

鉴定预测胚胎着床成功的生物标志物:从单组学到多组学的应用,以改善生殖结局。

Identifying biomarkers for predicting successful embryo implantation: applying single to multi-OMICs to improve reproductive outcomes.

机构信息

IVI-RMA Alicante, Innovation. Avda. de Denia 111, 03015 Alicante, Spain.

Fundación IVI, Innovation-IIS La Fe, Avda. Fernando Abril Martorell 106, Torre A, 1° 1.23, 46026 Valencia, Spain.

出版信息

Hum Reprod Update. 2020 Feb 28;26(2):264-301. doi: 10.1093/humupd/dmz042.

Abstract

BACKGROUND

Successful embryo implantation is a complex process that requires the coordination of a series of events, involving both the embryo and the maternal endometrium. Key to this process is the intricate cascade of molecular mechanisms regulated by endocrine, paracrine and autocrine modulators of embryonic and maternal origin. Despite significant progress in ART, implantation failure still affects numerous infertile couples worldwide and fewer than 10% of embryos successfully implant. Improved selection of both the viable embryos and the optimal endometrial phenotype for transfer remains crucial to enhancing implantation chances. However, both classical morphological embryo selection and new strategies incorporated into clinical practice, such as embryonic genetic analysis, morphokinetics or ultrasound endometrial dating, remain insufficient to predict successful implantation. Additionally, no techniques are widely applied to analyse molecular signals involved in the embryo-uterine interaction. More reliable biological markers to predict embryo and uterine reproductive competence are needed to improve pregnancy outcomes. Recent years have seen a trend towards 'omics' methods, which enable the assessment of complete endometrial and embryonic molecular profiles during implantation. Omics have advanced our knowledge of the implantation process, identifying potential but rarely implemented biomarkers of successful implantation.

OBJECTIVE AND RATIONALE

Differences between the findings of published omics studies, and perhaps because embryonic and endometrial molecular signatures were often not investigated jointly, have prevented firm conclusions being reached. A timely review summarizing omics studies on the molecular determinants of human implantation in both the embryo and the endometrium will help facilitate integrative and reliable omics approaches to enhance ART outcomes.

SEARCH METHODS

In order to provide a comprehensive review of the literature published up to September 2019, Medline databases were searched using keywords pertaining to omics, including 'transcriptome', 'proteome', 'secretome', 'metabolome' and 'expression profiles', combined with terms related to implantation, such as 'endometrial receptivity', 'embryo viability' and 'embryo implantation'. No language restrictions were imposed. References from articles were also used for additional literature.

OUTCOMES

Here we provide a complete summary of the major achievements in human implantation research supplied by omics approaches, highlighting their potential to improve reproductive outcomes while fully elucidating the implantation mechanism. The review highlights the existence of discrepancies among the postulated biomarkers from studies on embryo viability or endometrial receptivity, even using the same omic analysis.

WIDER IMPLICATIONS

Despite the huge amount of biomarker information provided by omics, we still do not have enough evidence to link data from all omics with an implantation outcome. However, in the foreseeable future, application of minimally or non-invasive omics tools, together with a more integrative interpretation of uniformly collected data, will help to overcome the difficulties for clinical implementation of omics tools. Omics assays of the embryo and endometrium are being proposed or already being used as diagnostic tools for personalised single-embryo transfer in the most favourable endometrial environment, avoiding the risk of multiple pregnancies and ensuring better pregnancy rates.

摘要

背景

成功的胚胎着床是一个复杂的过程,需要一系列事件的协调,涉及胚胎和母体子宫内膜。这个过程的关键是胚胎和母体来源的内分泌、旁分泌和自分泌调节剂的复杂级联分子机制。尽管在辅助生殖技术方面取得了重大进展,但着床失败仍然影响着全球众多不孕夫妇,只有不到 10%的胚胎成功着床。提高对有活力胚胎和最佳子宫内膜表型的选择对于提高着床机会仍然至关重要。然而,经典的胚胎形态学选择和新的策略,如胚胎遗传分析、形态动力学或超声子宫内膜日期,仍然不足以预测成功的着床。此外,没有技术广泛应用于分析胚胎-子宫相互作用中涉及的分子信号。需要更可靠的生物学标志物来预测胚胎和子宫的生殖能力,以提高妊娠结局。近年来,人们越来越关注“组学”方法,这些方法可以评估着床过程中完整的子宫内膜和胚胎分子谱。组学方法提高了我们对着床过程的认识,确定了成功着床的潜在但很少实施的生物标志物。

目的和理由

发表的组学研究结果存在差异,也许是因为胚胎和子宫内膜的分子特征通常没有联合进行研究,因此无法得出明确的结论。及时总结组学研究胚胎和子宫内膜中人类着床分子决定因素的综述,将有助于促进整合和可靠的组学方法来提高辅助生殖技术的结果。

检索方法

为了全面综述截至 2019 年 9 月发表的文献,使用与组学相关的关键词,包括“转录组”、“蛋白质组”、“分泌组”、“代谢组”和“表达谱”,以及与着床相关的术语,如“子宫内膜容受性”、“胚胎活力”和“胚胎着床”,在 Medline 数据库中进行了搜索。未对语言进行限制。还使用了文章中的参考文献来获取额外的文献。

结果

在这里,我们提供了通过组学方法获得的人类着床研究的主要成果的完整总结,突出了它们改善生殖结局的潜力,同时充分阐明了着床机制。该综述强调了即使使用相同的组学分析,从胚胎活力或子宫内膜容受性研究中提出的假定生物标志物之间也存在差异。

更广泛的影响

尽管组学提供了大量的生物标志物信息,但我们仍然没有足够的证据将所有组学的数据与着床结果联系起来。然而,在可预见的未来,应用微创或非侵入性的组学工具,以及更综合地解释统一收集的数据,将有助于克服组学工具临床应用的困难。胚胎和子宫内膜的组学分析被提议或已经被用作在最有利的子宫内膜环境中进行个体化单胚胎转移的诊断工具,避免多胎妊娠的风险,并确保更好的妊娠率。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验